Medpace Holdings, Inc. (MEDP)Healthcare | Diagnostics & Research | Cincinnati, United States | NasdaqGS
600.65 USD
-10.92
(-1.786%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 600.65 |
Hot Take ↕ | Aug. 22, 2026, 4:58 a.m. EDT
Medpace is a high-octane compounder with exceptional fundamentals—revenue growing 17 percent, earnings surging 37 percent, and return on equity exceeding 160 percent. The nine-year price history confirms the market has rewarded this quality handsomely, climbing nearly 1500 percent over the period. However, the short-term picture is mixed. While the stock recently beat earnings and raised guidance, triggering a 17 percent jump, insiders have been selling significant amounts of stock, including the CEO trading over $4 million. This misalignment between management and shareholders tempers the enthusiasm. The options market reflects this tension: speculators are placing heavy call bets targeting a $640 to $680 range while simultaneously buying deep put protection around $560 to $570. Valuation is steep at 36 times earnings, and analyst targets lag the current price, suggesting a potential pullback is priced in. Long-term, the business remains a fortress, but short-term volatility is likely given the insider activity and stretched multiples. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.079556 |
| AutoARIMA | 0.094171 |
| MSTL | 0.107753 |
| AutoETS | 0.114835 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 4.39 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.253 |
| Excess Kurtosis | -1.11 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 33.216 |
| Revenue per Share | 98.469 |
| Market Cap | 16,765,136,896 |
| Trailing P/E | 35.84 |
| Forward P/E | 31.11 |
| Beta | 1.15 |
| Profit Margins | 17.66% |
| Website | https://www.medpace.com |
As of Aug. 22, 2026, 4:58 a.m. EDT: Speculators are positioning for a range-bound recovery with bullish call bets concentrated at the $640 to $680 range for December 2026 expiration, while put buyers are establishing a floor around $560 to $570. Deep out-of-the-money puts show inflated implied volatility, suggesting fear of a sharp downside move despite the overall call-heavy positioning.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.29203105 |
| Address1 | 5,375 Medpace Way |
| All Time High | 677.9 |
| All Time Low | 21.76 |
| Ask | 620.8 |
| Ask Size | 1 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 194,620 |
| Average Daily Volume3 Month | 303,840 |
| Average Volume | 303,840 |
| Average Volume10Days | 194,620 |
| Beta | 1.151 |
| Bid | 604.56 |
| Bid Size | 1 |
| Board Risk | 8 |
| Book Value | 15.545 |
| City | Cincinnati |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 600.65 |
| Current Ratio | 0.732 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 609.215 |
| Day Low | 599.36 |
| Debt To Equity | 33.216 |
| Display Name | Medpace |
| Earnings Call Timestamp End | 1,784,811,600 |
| Earnings Call Timestamp Start | 1,784,811,600 |
| Earnings Growth | 0.371 |
| Earnings Quarterly Growth | 0.345 |
| Earnings Timestamp | 1,784,750,400 |
| Earnings Timestamp End | 1,792,440,000 |
| Earnings Timestamp Start | 1,792,440,000 |
| Ebitda | 611,200,000 |
| Ebitda Margins | 0.21968001 |
| Enterprise To Ebitda | 26.843 |
| Enterprise To Revenue | 5.897 |
| Enterprise Value | 16,406,559,744 |
| Eps Current Year | 17.70463 |
| Eps Forward | 19.31014 |
| Eps Trailing Twelve Months | 16.76 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 513 579 0444 |
| Fifty Day Average | 560.5324 |
| Fifty Day Average Change | 40.117615 |
| Fifty Day Average Change Percent | 0.07157055 |
| Fifty Two Week Change Percent | 29.203106 |
| Fifty Two Week High | 677.9 |
| Fifty Two Week High Change | -77.25 |
| Fifty Two Week High Change Percent | -0.11395486 |
| Fifty Two Week Low | 373.0 |
| Fifty Two Week Low Change | 227.65002 |
| Fifty Two Week Low Change Percent | 0.61032176 |
| Fifty Two Week Range | 373.0 - 677.9 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,470,922,200,000 |
| Float Shares | 22,455,764 |
| Forward Eps | 19.31014 |
| Forward P E | 31.10542 |
| Free Cashflow | 510,396,512 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 6,500 |
| Fullday Change | -10.92 |
| Fullday Change Percent | -1.78557 |
| Fullday Price | 600.65 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.7235 |
| Gross Profits | 2,012,973,056 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.19479999 |
| Held Percent Institutions | 0.91549003 |
| Implied Shares Outstanding | 27,911,655 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. |
| Long Name | Medpace Holdings, Inc. |
| Market | us_market |
| Market Cap | 16,765,136,896 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_260345878 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 491,500,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 17,048,159,757 |
| Number Of Analyst Opinions | 12 |
| Open | 605.79 |
| Operating Cashflow | 752,659,968 |
| Operating Margins | 0.20757 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 3.27 |
| Phone | 513 579 9911 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 600.65 |
| Post Market Time | 1,787,959,804 |
| Previous Close | 611.57 |
| Price Eps Current Year | 33.926155 |
| Price Hint | 2 |
| Price To Book | 38.639435 |
| Price To Sales Trailing12 Months | 6.0256658 |
| Profit Margins | 0.17665 |
| Quick Ratio | 0.658 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -10.92 |
| Regular Market Change Percent | -1.78557 |
| Regular Market Day High | 609.215 |
| Regular Market Day Low | 599.36 |
| Regular Market Day Range | 599.36 - 609.215 |
| Regular Market Open | 605.79 |
| Regular Market Previous Close | 611.57 |
| Regular Market Price | 600.65 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 186,746 |
| Return On Assets | 0.20096001 |
| Return On Equity | 1.6215401 |
| Revenue Growth | 0.172 |
| Revenue Per Share | 98.469 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 27,911,655 |
| Shares Percent Shares Out | 0.056599997 |
| Shares Short | 1,578,593 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,190,722 |
| Short Name | Medpace Holdings, Inc. |
| Short Percent Of Float | 0.0706 |
| Short Ratio | 4.61 |
| Source Interval | 15 |
| State | OH |
| Symbol | MEDP |
| Target High Price | 692.0 |
| Target Low Price | 370.0 |
| Target Mean Price | 581.8333 |
| Target Median Price | 604.5 |
| Total Cash | 502,688,000 |
| Total Cash Per Share | 18.01 |
| Total Debt | 144,112,000 |
| Total Revenue | 2,782,287,872 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 16.76 |
| Trailing P E | 35.838306 |
| Trailing Peg Ratio | 3.2697 |
| Triggerable | 1 |
| Two Hundred Day Average | 520.82245 |
| Two Hundred Day Average Change | 79.827576 |
| Two Hundred Day Average Change Percent | 0.15327215 |
| Type Disp | Equity |
| Volume | 186,746 |
| Website | https://www.medpace.com |
| Zip | 45,227 |